China’s biotech firms move up value chain as drug deals evolve beyond licensing: analysts

By South China Morning Post | Created at 2026-09-26 01:11:58 | Updated at 2026-09-26 01:56:03 55 minutes ago

1. Homepage
2. Asia
3. China’s biotech firms move up value chain as drug deals evolve beyond licensing: analysts